Time-to-target Dosing
Time-To-Target Dosing is a pharmacokinetic dosing metric that quantifies the duration required for a patient to reach a predefined therapeutic drug exposure target following initiation or adjustment of pharmacotherapy.
4
Publications
132
Citations
25
Authors
12
Institutions
Publications per year
2017–2026
1
Parents
4
Takashi Kadowaki, Hideaki Jinnouchi, Kohei Kaku et al. · Journal of Diabetes Investigation · 2016 · 14 citations · Full text
Yumei Zhang, Lin Zhu, Xianlin Zhao et al. · World Journal of Gastroenterology · 2017 · 10 citations · Full text
1–5 of 4
25
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 25
12
University of Michigan
Ann Arbor, United States
1 h-index
4 publications
40 citations

University of Washington Medical Center
Seattle, United States
1 h-index
5 publications
445 citations

Novo Nordisk (Denmark)
Copenhagen, Denmark
1 h-index
1 publications
14 citations
The University of Tokyo
Tokyo, Japan
1 h-index
1 publications
14 citations
Michigan Medicine
Ann Arbor, United States
1 h-index
4 publications
40 citations
Kawasaki Medical School
Kurashiki, Japan
1 h-index
1 publications
14 citations

University of British Columbia
Vancouver, Canada
1 h-index
5 publications
95 citations
Centre Hospitalier De Pau
Pau, France
1 h-index
1 publications
89 citations
1–8 of 12
1 publications · 19 citations
1
h-index
ACAAI · 1 publications · 10 citations
1
h-index
1 publications · 89 citations
1
h-index
JDI · 1 publications · 14 citations
1
h-index
WJG · 1 publications · 10 citations
1–5